Novartis.com - SEO Checker

¡Registrarme gratis! Exportar PDF
Visión general del análisis SEO
Metadatos
80% 
Calidad de la página
74% 
Estructura
100% 
Enlazado
26% 
Servidor
100% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
0,38 s
Tamaño HTML
203,20 kB
Palabras
1246
Medios
22
Cantidad de enlaces
341 internos / 12 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
Novartis
El título es demasiado corto (73 píxeles de un máximo de 580 píxeles).Optimizar ahora
El título está compuesto por una sola palabra.
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
Working together, we can reimagine medicine to improve and extend people’s lives.
La longitud de la meta descripción es óptima (512 píxeles de una longitud máxima de 1000 píxeles).
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
https://www.novartis.com/
La página tiene una redirección canónica correcta.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en
Ubicación geográfica del servidor: Canadá
El idioma ha sido correctamente declarado en el código HTML: en.
Enlaces Alternate/Hreflang
(Poco importante)
No se identifica ningún error en los enlaces alternate/hreflang.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
abstractWorking together, we can reimagine medicine to improve and extend people’s lives.
google-site-verificationoWLifsm3cWEQxnH7h2q7auXVJgDapVcYDRjNg1rESi4
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1, shrink-to-fit=no
langen
twitter:cardsummary_large_image
twitter:site@novartis
twitter:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
twitter:titleNovartis
twitter:site:id17226612
twitter:creator:id17226612
twitter:creator@novartis
twitter:urlhttps://www.novartis.com/home
twitter:imagehttps://www.novartis.com/sites/novartis_com/files/novartis-logo-open-graph.jpg
twitter:image:altNovartis logo
og:site_nameNovartis
og:typeWebsite
og:urlhttps://www.novartis.com/home
og:titleNovartis
og:descriptionWorking together, we can reimagine medicine to improve and extend people’s lives.
og:imagehttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:secure_urlhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
og:image:altNovartis logo
x-ua-compatibleie=edge
charsetutf-8

¡Analiza ya hasta 25.000 páginas de novartis.com!

Probar gratis
Garantizada la gratuidad durante la fase de prueba.

Calidad de la página

Contenido
(Extremadamente importante)
Algunas palabras del encabezado H1 no se repiten en el cuerpo del texto.
El número total de palabras en la página es bueno: 1246 palabras.
Un 15.3% del contenido está constituido por palabras vacías.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 13 párrafos en esta página.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 13 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
No se ha especificado ningún icono de Apple Touch.
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1, shrink-to-fit=no).
Etiquetas Bold y Strong
(Poco importante)
Hay demasiadas etiquetas de negritas en esta página: 127. Utiliza un máximo de 25 etiquetas.
Algunas etiquetas se repiten, como por ejemplo: international.
Optimización de imágenes
(Poco importante)
La descripción del atributo ALT se utiliza correctamente en todas las imágenes rastreadas.
Redes Sociales
(Deseable)
Esta página está perfectamente optimizada para las redes sociales.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
/themes/custom/polaris/logo.svgNovartisHome
.../polaris/patterns/images/icon-search.svgOpen
...m/polaris/patterns/images/icon-close.svgClose
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...custom/polaris/patterns/images/globe.svglanguage-selector-globe
...bed-kid-room-menu.jpg.webp?itok=6RZr5Lb7Mother and daughter cuddling on a bed in a kids roomMother and daughter cuddling on a bed in a kids room
...ench-in-park-menu.jpg.webp?itok=C15Fc3fFAdult daughter talking to her senior parents on a bench in a parkAdult daughter talking to her senior parents on a bench in a park
...patient-in-office.jpg.webp?itok=HtKzFn-pDoctor discussing illness with patient in an officeDoctor discussing illness with patient in an office
...ientist-cambridge.jpg.webp?itok=nAcv-yKNA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...nds-party-at-home.jpg.webp?itok=FS12EXewFamily and friends having a party at homeFamily and friends having a party at home
...ptop-on-sofa-menu.jpg.webp?itok=bH-X-V18Business woman working on her laptop in a bright atmosphereBusiness woman working on her laptop in a bright atmosphere
...11/news-hero-menu.jpg.webp?itok=OeYNijgYOverhead view of a meeting room with people in the foreground and screens in the backgroundOverhead view of a meeting room with people in the foreground and screens in the background
...-people-mega-menu.jpg.webp?itok=dz36nQMYTwo business peopleTwo business people
...ing-on-beach-menu.jpg.webp?itok=18W4Jg_tGrandmother, mother and daughter smiling and laughing on a beachGrandmother, mother and daughter smiling and laughing on a beach
...0r0wz0d1/version/100001.jpg/height/674pxscientist-looking-at-a-screen
...hess-and-laughing.jpg.webp?itok=4ubTg8y7Two men, seated indoors around a table, engaged in a conversation and playing chessTwo men, seated indoors around a table, engaged in a conversation and playing chess
...ientist-cambridge.jpg.webp?itok=GLon0edOA female research scientist in a lab looking at a sampleA female research scientist in a lab looking at a sample
...ling-and-laughing.jpg.webp?itok=VK291-kxGroup of warm clothed women, seated outside, smiling and laughingGroup of warm clothed women, seated outside, smiling and laughing
...025-media-content.jpg.webp?itok=buTgDVrfQ2 2025Q2 2025
...rch-lab-Cambridge.jpg.webp?itok=AR-v2AfMHigh resolution picture of an artificial heart muscle from a research lab in Cambridge.High resolution picture of an artificial heart muscle from a research lab in Cambridge.
...-laughing-in-body.jpg.webp?itok=hG3uYA-HThree business people laughingThree business people laughing
...-and-her-labrador.jpg.webp?itok=4HIqaVLdKate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, FloridaKate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Estructura de la página

Encabezado H1
(Extremadamente importante)
Reimagining medicine, together
El encabezado H1 es óptimo.
Encabezados
(Importante)
Los encabezados H están perfectamente ordenados.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 Reimagining medicine, together
H2 Novartis Financial Results – Q2 2025
H2 Latest news
H2 Live. Magazine
H2 Welcome to where we thrive together
H2 Novartis in Society Integrated Report 2024
H2 Resource links
H2 Novartis
H3 Discover our medicines
H3 Explore our science
H3 Learn about our impact
H3 Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
H3 Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
H3 Novartis receives approval for first malaria medicine for newborn babies and young infants
Algunos textos ancla son demasiado largos.
Algunos textos ancla se repiten más de una vez en varios enlaces.
La cantidad de enlaces internos es adecuada.
Ningún enlace interno contiene parámetros dinámicos.
Hay 12 enlaces externos en esta página.

Enlaces detectados en esta página

EnlacePropiedadesTexto ancla
https://www.novartis.com/Texto ancla Skip to main content
https://www.novartis.com/IMG-ALT Novartis
https://www.novartis.com/Texto ancla International
https://www.novartis.com/Texto ancla Americas
https://www.novartis.com/Texto ancla Asia Pacific
https://www.novartis.com/Texto ancla Europe
https://www.novartis.com/Texto ancla Middle East & Africa
https://www.novartis.com/Subdominio Global | English
https://www.novartisfoundation...Externo Subdominio Novartis Foundation | English
https://www.novartis.com/ar-es/Subdominio Argentina | Español
https://www.novartis.com/br-pt/Subdominio Brazil | Português
https://www.novartis.com/ca-en/Subdominio Canada | English
https://www.novartis.com/ca-fr/Subdominio Canada | Français
/candean-es/Subdominio Central America | Español
https://www.novartis.com/co-es/Subdominio Colombia | Español
https://www.novartis.com/mx-es/Subdominio Mexico | Español
https://www.novartis.com/us-en/Subdominio United States | English
https://www.novartis.com/au-en/Subdominio Australia | English
https://www.novartis.com/hk-zh/Subdominio Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/in-en/Subdominio India | English
https://www.novartis.com/id-en/Subdominio Indonesia | English
https://www.novartis.com/jp-ja/Subdominio Japan | 日本語
https://www.novartis.com/kr-ko/Subdominio Korea | 한국어
https://www.novartis.com.cn/Externo Subdominio Mainland China | 中文
https://www.novartis.com/my-en/Subdominio Malaysia | English
https://www.novartis.com/pk-en/Subdominio Pakistan | English
https://www.novartis.com/ph-en/Subdominio Philippines | English
https://www.novartis.com/sg-en/Subdominio Singapore | English
https://www.novartis.com/tw-zh/Subdominio Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdominio Thailand | ภาษาไทย
https://www.novartis.com/at-de/Subdominio Austria | Deutsch
https://www.novartis.com/be-fr/Subdominio Belgium | Français
https://www.novartis.com/be-nl/Subdominio Belgium | Nederlands
https://www.novartis.com/bg-bg/Subdominio Bulgaria | Български
https://www.novartis.com/cz-cs/Subdominio Czech Republic | Česky
https://www.novartis.com/cz-en/Subdominio Czech Republic | English
https://www.novartis.com/dk-da/Subdominio Denmark | Dansk
https://www.novartis.com/ee-et/Subdominio Estonia | Eesti
https://www.novartis.com/fi-fi/Subdominio Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdominio France | Français
https://www.novartis.com/de-de/Subdominio Germany | Deutsch
https://www.novartis.com/gr-el/Subdominio Greece | Ελληνικά
https://www.novartis.com/hu-hu/Subdominio Hungary | Magyar
https://www.novartis.com/ie-en/Subdominio Ireland | English
https://www.novartis.com/it-it/Subdominio Italy | Italiano
https://www.novartis.com/lv-lv/Subdominio Latvia | Latvian
https://www.novartis.com/lt-lt/Subdominio Lithuania | Lithuanian
https://www.novartis.com/nl-nl/Subdominio Netherlands | Nederlands
https://www.novartis.com/no-no/Subdominio Norway | Norsk
https://www.novartis.com/pl-pl/Subdominio Poland | Polski
https://www.novartis.com/pt-pt/Subdominio Portugal | Português
https://www.novartis.com/ro-ro/Subdominio Romania | Română
https://www.novartis.com/ru-ru/Subdominio Russia | Русский
https://www.novartis.com/rs-sr/Subdominio Serbia | Srpski
https://www.novartis.com/sk-sk/Subdominio Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdominio Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdominio Slovenia | English
https://www.novartis.com/es-es/Subdominio Spain | Español
https://www.novartis.com/se-se/Subdominio Sweden | Svenska
https://www.novartis.com/ch-de/Subdominio Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdominio Switzerland | Français
https://www.novartis.com/tr-tr/Subdominio Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdominio United Kingdom | English
https://www.novartis.com/eg-en/Subdominio Egypt | English
https://www.novartis.com/il-he/Subdominio Israel | עברית
https://www.novartis.com/sa-ar/Subdominio Saudi Arabia | العربية
https://www.novartis.com/za-en/Subdominio South Africa | English
https://www.novartis.com/Texto ancla Texto duplicado International
https://www.novartis.com/Texto ancla Texto duplicado Americas
https://www.novartis.com/Texto ancla Texto duplicado Asia Pacific
https://www.novartis.com/Texto ancla Texto duplicado Europe
https://www.novartis.com/Texto ancla Texto duplicado Middle East & Africa
https://www.novartis.com/ar-es/Subdominio Texto duplicado Argentina | Español
https://www.novartis.com/au-en/Subdominio Texto duplicado Australia | English
https://www.novartis.com/at-de/Subdominio Texto duplicado Austria | Deutsch
https://www.novartis.com/be-fr/Subdominio Texto duplicado Belgium | Français
https://www.novartis.com/be-nl/Subdominio Texto duplicado Belgium | Nederlands
https://www.novartis.com/br-pt/Subdominio Texto duplicado Brazil | Português
https://www.novartis.com/bg-bg/Subdominio Texto duplicado Bulgaria | Български
https://www.novartis.com/ca-en/Subdominio Texto duplicado Canada | English
https://www.novartis.com/ca-fr/Subdominio Texto duplicado Canada | Français
/candean-es/Subdominio Texto duplicado Central America | Español
https://www.novartis.com/co-es/Subdominio Texto duplicado Colombia | Español
https://www.novartis.com/cz-cs/Subdominio Texto duplicado Czech Republic | Česky
https://www.novartis.com/cz-en/Subdominio Texto duplicado Czech Republic | English
https://www.novartis.com/dk-da/Subdominio Texto duplicado Denmark | Dansk
https://www.novartis.com/eg-en/Subdominio Texto duplicado Egypt | English
https://www.novartis.com/ee-et/Subdominio Texto duplicado Estonia | Eesti
https://www.novartis.com/fi-fi/Subdominio Texto duplicado Finland | Suomalainen
https://www.novartis.com/fr-fr/Subdominio Texto duplicado France | Français
https://www.novartis.com/de-de/Subdominio Texto duplicado Germany | Deutsch
https://www.novartis.com/gr-el/Subdominio Texto duplicado Greece | Ελληνικά
https://www.novartis.com/hk-zh/Subdominio Texto duplicado Hong Kong S.A.R. | 繁體中文
https://www.novartis.com/hu-hu/Subdominio Texto duplicado Hungary | Magyar
https://www.novartis.com/in-en/Subdominio Texto duplicado India | English
https://www.novartis.com/id-en/Subdominio Texto duplicado Indonesia | English
https://www.novartis.com/ie-en/Subdominio Texto duplicado Ireland | English
https://www.novartis.com/il-he/Subdominio Texto duplicado Israel | עברית
https://www.novartis.com/it-it/Subdominio Texto duplicado Italy | Italiano
https://www.novartis.com/jp-ja/Subdominio Texto duplicado Japan | 日本語
https://www.novartis.com/kr-ko/Subdominio Texto duplicado Korea | 한국어
https://www.novartis.com/lv-lv/Subdominio Texto duplicado Latvia | Latvian
https://www.novartis.com/lt-lt/Subdominio Texto duplicado Lithuania | Lithuanian
https://www.novartis.com.cn/Externo Subdominio Texto duplicado Mainland China | 中文
https://www.novartis.com/my-en/Subdominio Texto duplicado Malaysia | English
https://www.novartis.com/mx-es/Subdominio Texto duplicado Mexico | Español
https://www.novartis.com/nl-nl/Subdominio Texto duplicado Netherlands | Nederlands
https://www.novartis.com/no-no/Subdominio Texto duplicado Norway | Norsk
https://www.novartis.com/Subdominio Texto duplicado Global | English
https://www.novartisfoundation...Externo Subdominio Texto duplicado Novartis Foundation | English
https://www.novartis.com/pk-en/Subdominio Texto duplicado Pakistan | English
https://www.novartis.com/ph-en/Subdominio Texto duplicado Philippines | English
https://www.novartis.com/pl-pl/Subdominio Texto duplicado Poland | Polski
https://www.novartis.com/pt-pt/Subdominio Texto duplicado Portugal | Português
https://www.novartis.com/ro-ro/Subdominio Texto duplicado Romania | Română
https://www.novartis.com/ru-ru/Subdominio Texto duplicado Russia | Русский
https://www.novartis.com/sa-ar/Subdominio Texto duplicado Saudi Arabia | العربية
https://www.novartis.com/rs-sr/Subdominio Texto duplicado Serbia | Srpski
https://www.novartis.com/sg-en/Subdominio Texto duplicado Singapore | English
https://www.novartis.com/sk-sk/Subdominio Texto duplicado Slovakia | Slovensky
https://www.novartis.com/si-sl/Subdominio Texto duplicado Slovenia | Slovenščina
https://www.novartis.com/si-en/Subdominio Texto duplicado Slovenia | English
https://www.novartis.com/za-en/Subdominio Texto duplicado South Africa | English
https://www.novartis.com/es-es/Subdominio Texto duplicado Spain | Español
https://www.novartis.com/se-se/Subdominio Texto duplicado Sweden | Svenska
https://www.novartis.com/ch-de/Subdominio Texto duplicado Switzerland | Deutsch
https://www.novartis.com/ch-fr/Subdominio Texto duplicado Switzerland | Français
https://www.novartis.com/tw-zh/Subdominio Texto duplicado Taiwan | 繁體中文
https://www.novartis.com/th-th/Subdominio Texto duplicado Thailand | ภาษาไทย
https://www.novartis.com/tr-tr/Subdominio Texto duplicado Türkiye | Türkçe
https://www.novartis.com/uk-en/Subdominio Texto duplicado United Kingdom | English
https://www.novartis.com/us-en/Subdominio Texto duplicado United States | English
https://www.novartis.com/aboutAbout
A-TITLE About
/about/board-directorsBoard of Directors
A-TITLE Board of Directors
/about/board-directors/giovann...Giovanni Caforio
A-TITLE Giovanni Caforio
/about/board-directors/simon-m...Simon Moroney
A-TITLE Simon Moroney
/about/board-directors/nancy-c...Nancy C. Andrews
A-TITLE Nancy C. Andrews
/about/board-directors/ton-bue...Ton Buechner
A-TITLE Ton Buechner
/about/board-directors/patrice...Patrice Bula
A-TITLE Patrice Bula
/about/board-directors/elizabe...Elizabeth (Liz) Doherty
A-TITLE Elizabeth (Liz) Doherty
/about/board-directors/ana-de-...Ana de Pro Gonzalo
A-TITLE Ana de Pro Gonzalo
/about/board-directors/bridget...Bridgette Heller
A-TITLE Bridgette Heller
/about/board-directors/daniel-...Daniel Hochstrasser
A-TITLE Daniel Hochstrasser
/about/board-directors/frans-v...Frans van Houten
A-TITLE Frans van Houten
/about/board-directors/elizabe...Elizabeth McNally
A-TITLE Elizabeth McNally
/about/board-directors/john-d-...John D. Young
A-TITLE John D. Young
/about/board-directors/charlot...Charlotte Pamer-Wieser
A-TITLE Charlotte Pamer-Wieser
/about/executive-committeeExecutive Committee
A-TITLE Executive Committee
/about/executive-committee/vas...Vasant (Vas) Narasimhan
A-TITLE Vasant (Vas) Narasimhan
/about/executive-committee/shr...Shreeram Aradhye
A-TITLE Shreeram Aradhye
/about/executive-committee/vic...Victor Bulto
A-TITLE Victor Bulto
/about/executive-committee/aha...Aharon (Ronny) Gal
A-TITLE Aharon (Ronny) Gal
/about/executive-committee/kar...Karen L. Hale
A-TITLE Karen L. Hale
/about/executive-committee/pat...Patrick Horber
A-TITLE Patrick Horber
/about/executive-committee/har...Harry Kirsch
A-TITLE Harry Kirsch
/about/executive-committee/rob...Rob Kowalski
A-TITLE Rob Kowalski
/about/executive-committee/ste...Steffen Lang
A-TITLE Steffen Lang
/about/executive-committee/fio...Fiona Marshall
A-TITLE Fiona Marshall
/about/executive-committee/lut...Lutz Hegemann
A-TITLE Lutz Hegemann
/about/executive-committee/ter...Teresa Jose
A-TITLE Teresa Jose
/about/executive-committee/mic...Michelle Weese
A-TITLE Michelle Weese
/about/productsProducts
A-TITLE Products
/about/therapeutic-areasTherapeutic areas
A-TITLE Therapeutic areas
/about/therapeutic-areas/cardi...Cardiovascular, renal and metabolic
A-TITLE Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Immunology
A-TITLE Immunology
/about/therapeutic-areas/neuro...Neuroscience
A-TITLE Neuroscience
/about/therapeutic-areas/oncologyOncology
A-TITLE Oncology
/about/people-and-culturePeople and culture
A-TITLE People and culture
/about/inclusionInclusion
A-TITLE Inclusion
/about/inclusion/promoting-inc...Promoting inclusion
A-TITLE Promoting inclusion
/about/inclusion/building-belo...Building belonging
A-TITLE Building belonging
/about/inclusion/parental-leaveParental leave
A-TITLE Parental leave
/about/inclusion/caring-mental...Caring for the mental health and wellbeing of our people
A-TITLE Caring for the mental health and wellbeing of our people
/about/novartis-gene-therapiesNovartis Gene Therapies
A-TITLE Novartis Gene Therapies
/about/manufacturingManufacturing
A-TITLE Manufacturing
/about/qualityQuality
A-TITLE Quality
/about/quality/audit-programAudit program
A-TITLE Audit program
/about/quality/novartis-qualit...Novartis quality management system (QMS)
A-TITLE Novartis quality management system (QMS)
/about/quality/product-and-pat...Product and patient safety training
A-TITLE Product and patient safety training
/about/quality/regulatory-insp...Regulatory inspections
A-TITLE Regulatory inspections
/about/quality/product-recallsProduct recalls
A-TITLE Product recalls
/about/quality/third-party-sup...Third-party suppliers
A-TITLE Third-party suppliers
/about/novartis-and-european-u...Novartis and the European Union (EU)
A-TITLE Novartis and the European Union (EU)
/about/awards-and-recognitionAwards and recognition
A-TITLE Awards and recognition
/patients-and-caregiversPatients and caregivers
A-TITLE Patients and caregivers
/patients-and-caregivers/novar...Novartis commitment to patients and caregivers
A-TITLE Novartis commitment to patients and caregivers
https://www.novartis.com/diseasesDiseases
A-TITLE Diseases
/investors/reporting-and-trans...Patient organization funding
A-TITLE Patient organization funding
/news/stories/patient-perspect...Patients perspectives stories
A-TITLE Patients perspectives stories
/healthcare-professionalsHealthcare professionals
A-TITLE Healthcare professionals
/healthcare-professionals/medi...Medical congresses and events
A-TITLE Medical congresses and events
/healthcare-professionals/medi...ASCO Annual Meeting
A-TITLE ASCO Annual Meeting
/about/productsTexto duplicado Products
A-TITLE Products
/research-development/novartis...Novartis pipeline
A-TITLE Novartis pipeline
/healthcare-professionals/mana...Managed access programs
A-TITLE Managed access programs
/healthcare-professionals/mana...Zolgensma® Global Managed Access Program (gMAP)
A-TITLE Zolgensma® Global Managed Access Program (gMAP)
/healthcare-professionals/nova...Novartis external funding
A-TITLE Novartis external funding
/healthcare-professionals/heal...Healthcare professional resources by country
A-TITLE Healthcare professional resources by country
/healthcare-professionals/inve...Investigator-initiated trials / studies
A-TITLE Investigator-initiated trials / studies
/healthcare-professionals/nova...Novartis medical information
A-TITLE Novartis medical information
/healthcare-professionals/nova...Submit medical enquiry
A-TITLE Submit medical enquiry
/research-and-developmentResearch and development
A-TITLE Research and development
/research-and-development/tech...Technology platforms
A-TITLE Technology platforms
/research-and-development/rese...Research disease areas
A-TITLE Research disease areas
/research-and-development/rese...Cardiovascular and metabolic disease research at Novartis
A-TITLE Cardiovascular and metabolic disease research at Novartis
/research-and-development/rese...DAx: exploratory disease research at Novartis
A-TITLE DAx: exploratory disease research at Novartis
/research-and-development/rese...Global Health disease area research at Novartis
A-TITLE Global Health disease area research at Novartis
/research-and-development/rese...Immunology disease research at Novartis
A-TITLE Immunology disease research at Novartis
/research-and-development/rese...Neuroscience research at Novartis
A-TITLE Neuroscience research at Novartis
/research-and-development/rese...Oncology research at Novartis
A-TITLE Oncology research at Novartis
/research-development/novartis...Texto duplicado Novartis pipeline
A-TITLE Novartis pipeline
/research-and-development/rese...Research collaborations
A-TITLE Research collaborations
/research-and-development/coll...Collaborations
A-TITLE Collaborations
https://www.novartis.com/esgESG
A-TITLE ESG
/esg/accessAccess
A-TITLE Access
/esg/access/creating-sustainab...Creating sustainable business models
A-TITLE Creating sustainable business models
/esg/access/value-based-pricingValue-based pricing
A-TITLE Value-based pricing
/esg/access/sub-saharan-africaSub-Saharan Africa
A-TITLE Sub-Saharan Africa
/esg/access/donationsDonations
A-TITLE Donations
/esg/access/novartis-access-pr...Novartis access principles
A-TITLE Novartis access principles
/esg/access/novartis-oncology-...Novartis oncology access
A-TITLE Novartis oncology access
/esg/access/patents-and-licensingPatents and licensing
A-TITLE Patents and licensing
/esg/environmental-sustainabilityEnvironmental sustainability
A-TITLE Environmental sustainability
/esg/environmental-sustainabil...Climate
A-TITLE Climate
/esg/environmental-sustainabil...Nature - Waste
A-TITLE Nature - Waste
/esg/environmental-sustainabil...Nature - Water
A-TITLE Nature - Water
/esg/ethics-risk-and-complianceEthics, risk and compliance
A-TITLE Ethics, risk and compliance
/esg/ethics-risk-and-complianc...Ethical behavior
A-TITLE Ethical behavior
/esg/ethics-risk-and-complianc...Compliance
A-TITLE Compliance
/esg/ethics-risk-and-complianc...Human rights
A-TITLE Human rights
/esg/ethics-risk-and-complianc...Learning and engagement
A-TITLE Learning and engagement
/esg/ethics-risk-and-complianc...Integrated risk assurance
A-TITLE Integrated risk assurance
/esg/global-healthGlobal health
A-TITLE Global health
/esg/global-health/pandemic-pr...Pandemic preparedness
A-TITLE Pandemic preparedness
/esg/global-health/avoidable-b...Avoidable blindness
A-TITLE Avoidable blindness
/diseases/chagas-diseaseChagas disease
A-TITLE Chagas disease
/diseases/leprosyLeprosy
A-TITLE Leprosy
/diseases/malariaMalaria
A-TITLE Malaria
/diseases/sickle-cell-diseaseSickle cell disease (SCD)
A-TITLE Sickle cell disease (SCD)
https://www.novartisfoundation...Nueva ventana Externo Subdominio Novartis Foundation
A-TITLE Novartis Foundation
/about/inclusionTexto duplicado Inclusion
A-TITLE Inclusion
/esg/indexESG index
A-TITLE ESG index
/investors/reporting-and-trans...Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...ESG rating performance
A-TITLE ESG rating performance
/investors/reporting-and-trans...Targets
A-TITLE Targets
/investors/reporting-and-trans...Texto duplicado Patient organization funding
A-TITLE Patient organization funding
/investors/reporting-and-trans...Payments to healthcare professionals
A-TITLE Payments to healthcare professionals
/investors/reporting-and-trans...Public policy
A-TITLE Public policy
/investors/reporting-and-trans...A living wage
A-TITLE A living wage
/investors/reporting-and-trans...A safe workplace
A-TITLE A safe workplace
/investors/reporting-and-trans...Animal research
A-TITLE Animal research
/investorsInvestors
A-TITLE Investors
/investors/event-calendarEvent calendar
A-TITLE Event calendar
/investors/financial-dataFinancial data
A-TITLE Financial data
/investors/financial-data/annu...Novartis annual results
A-TITLE Novartis annual results
/investors/financial-data/quar...Novartis quarterly results
A-TITLE Novartis quarterly results
/investors/financial-data/sec-...Novartis SEC filings
A-TITLE Novartis SEC filings
/investors/financial-data/prod...Product sales
A-TITLE Product sales
/investors/financial-data/fixe...Fixed-income securities
A-TITLE Fixed-income securities
/investors/financial-data/expe...Expected currency impact
A-TITLE Expected currency impact
/investors/share-data-and-anal...Share data and analysis
A-TITLE Share data and analysis
/investors/share-data-and-anal...Share monitor
A-TITLE Share monitor
/investors/share-data-and-anal...Dividend information
A-TITLE Dividend information
/investors/share-data-and-anal...Share ownership
A-TITLE Share ownership
/investors/share-data-and-anal...Share overview
A-TITLE Share overview
/investors/share-data-and-anal...Return on investment calculator
A-TITLE Return on investment calculator
/investors/shareholder-informa...Shareholder information
A-TITLE Shareholder information
/investors/shareholder-informa...General Meetings
A-TITLE General Meetings
/investors/shareholder-informa...American Depositary Receipts (ADR)
A-TITLE American Depositary Receipts (ADR)
/investors/shareholder-informa...Share buyback
A-TITLE Share buyback
/investors/shareholder-informa...Frequently asked questions
A-TITLE Frequently asked questions
/investors/company-overviewCompany overview
A-TITLE Company overview
/investors/company-overview/co...Corporate governance
A-TITLE Corporate governance
/investors/reporting-and-trans...Texto duplicado Reporting and transparency hub
A-TITLE Reporting and transparency hub
/investors/reporting-and-trans...Reporting archive
A-TITLE Reporting archive
/investors/reporting-and-trans...Texto duplicado ESG rating performance
A-TITLE ESG rating performance
/news/stay-up-to-datePublications order form
A-TITLE Publications order form
https://www.novartis.com/esgTexto duplicado ESG
A-TITLE ESG
https://www.novartis.com/newsNews
A-TITLE News
/news/newsroomNewsroom
A-TITLE Newsroom
/news/media-libraryMedia library
A-TITLE Media library
https://www.novartis.com/storiesStories
A-TITLE Stories
/news/stay-up-to-dateSubscribe
A-TITLE Subscribe
https://www.novartis.com/eventsEvents
A-TITLE Events
https://www.novartis.com/careersCareers
A-TITLE Careers
/careers/career-searchCareer search
A-TITLE Career search
/careers/our-business-functionsOur business functions
A-TITLE Our business functions
/careers/our-business-function...Careers in research and development
A-TITLE Careers in research and development
/careers/our-business-function...Careers in operations
A-TITLE Careers in operations
/careers/our-business-function...Careers in commercial and sales
A-TITLE Careers in commercial and sales
/careers/our-business-function...Careers in global functions
A-TITLE Careers in global functions
/careers/why-novartisWhy Novartis
A-TITLE Why Novartis
/careers/career-hubCareer hub
A-TITLE Career hub
https://novartis.willhire.co/Nueva ventana Externo Subdominio Temporary contracts
A-TITLE Temporary contracts
/careers/early-careersEarly careers
A-TITLE Early careers
/careers/early-careers/graduatesGraduates
A-TITLE Graduates
/careers/early-careers/studentsStudents
A-TITLE Students
/careers/early-careers/us-biom...US Biomedical Research internship programs
A-TITLE US Biomedical Research internship programs
/careers/early-careers/communi...Community exploration and learning lab (CELL)
A-TITLE Community exploration and learning lab (CELL)
/clinicaltrialsClinical trials
A-TITLE Clinical trials
/partneringPartnering
A-TITLE Partnering
/supplier-portalSupplier portal
A-TITLE Supplier portal
https://www.novartis.com/reportNueva ventana Report side effects
A-TITLE Report side effects
https://www.novartis.com/contactsContacts
A-TITLE Contacts
/about/therapeutic-areasDiscover our medicines Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
IMG-ALT Two men, seated indoors around a table, engaged in a conversation and playing chess
/research-and-developmentExplore our science Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
IMG-ALT A female research scientist in a lab looking at a sample
https://www.novartis.com/esgLearn about our impact Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
IMG-ALT Group of warm clothed women, seated outside, smiling and laughing
/events/novartis-financial-res...Learn more
A-TITLE Learn more
/news/media-releases/novartis-...Jul 17, 2025 Ad hoc release Novartis appoints Mukul Mehta as Chief Financial Officer, as Harry Kirsch retires after 22 years with the company
/news/media-releases/novartis-...Jul 17, 2025 Ad hoc release Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
/news/media-releases/novartis-...Jul 08, 2025 Press release Novartis receives approval for first malaria medicine for newborn babies and young infants
/news/newsroomAll news
A-TITLE All news
https://live.novartis.com/Nueva ventana Externo Subdominio Texto duplicado Learn more
A-TITLE Learn more
https://www.novartis.com/careersJoin us
A-TITLE Join us
/sites/novartis_com/files/nova...Nueva ventana Download the Integrated Report (PDF 5.0 MB)
A-TITLE Download the Integrated Report (PDF 5.0 MB)
https://www.novartis.com/aboutAbout Novartis
A-TITLE About Novartis
/healthcare-professionalsTexto duplicado Healthcare professionals
A-TITLE Healthcare professionals
/patients-and-caregiversTexto duplicado Patients and caregivers
A-TITLE Patients and caregivers
/research-development/novartis...Pipeline
A-TITLE Pipeline
/about/productsTexto duplicado Products
A-TITLE Products
/patients-and-caregiversTexto duplicado Patients and caregivers
/healthcare-professionalsTexto duplicado Healthcare professionals
/research-and-developmentResearchers
https://www.novartis.com/careersJob seekers
https://www.novartis.com/newsJournalists
/investorsTexto duplicado Investors
/events/novartis-financial-res...Q2 2025
/esg/accessTexto duplicado Access
https://www.novartis.com/esgTexto duplicado ESG
/esg/ethics-risk-and-complianc...SpeakUp
/research-development/novartis...Texto duplicado Pipeline
/about/productsTexto duplicado Products
/clinicaltrialsTexto duplicado Clinical trials
/partneringTexto duplicado Partnering
https://www.novartis.com/eventsTexto duplicado Events
/about/therapeutic-areas/cardi...Texto duplicado Cardiovascular, renal and metabolic
/about/therapeutic-areas/immun...Texto duplicado Immunology
/about/therapeutic-areas/neuro...Texto duplicado Neuroscience
/about/therapeutic-areas/oncologyTexto duplicado Oncology
https://www.linkedin.com/compa...Nueva ventana Externo Subdominio A-TITLE LinkedIn
https://www.facebook.com/novartisNueva ventana Externo Subdominio A-TITLE Facebook
https://x.com/novartisNueva ventana Externo A-TITLE X formerly known as Twitter
https://www.instagram.com/nova...Nueva ventana Externo Subdominio A-TITLE Instagram
https://www.youtube.com/user/n...Nueva ventana Externo Subdominio A-TITLE Youtube
/terms-useTerms of use
https://www.novartis.com/privacyPrivacy
https://www.novartis.com/Texto ancla Cookie settings
https://www.novartis.com/contactsTexto duplicado Contacts
/about/locationsLocations
/sitemap.xmlSite map
/open-sourceOpen source
/accessibilityWeb accessibility
/novartis-directoryNovartis Site Directory
A-TITLE Novartis Site Directory

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.novartis.com/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
El servidor web transmite la página web (HTML) comprimida.
Rendimiento
(Poco importante)
El tiempo de respuesta de la página HTML es excelente: 0,38 segundos, y se sitúa por debajo de los 0,40 segundos.
El tamaño HTML de la página es adecuado: 203 kB.

Cabecera HTTP

NombreValor
dateSat, 09 Aug 2025 05:54:11 GMT
content-typetext/html; charset=UTF-8
content-encodingbr
cf-ray96c4ff528ccadd47-CDG
cf-cache-statusHIT
age3204
cache-controlmax-age=60, public, s-maxage=2628000, stale-if-error=180, stale-while-revalidate=180
content-languageen
expiresSun, 19 Nov 1978 05:00:00 GMT
last-modifiedSat, 09 Aug 2025 01:48:38 GMT
strict-transport-securitymax-age=31536000; includeSubDomains
varyCookie,Accept-Encoding
viavarnish
content-security-policy-report-onlyscript-src 'self' 'unsafe-inline' 'unsafe-eval' https://unpkg.com https://acsbapp.com https://snap.licdn.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com https://cdnapisec.kaltura.com http://cdnapi.kaltura.com https://cfvod.kaltura.com https://www.google-analytics.com https://cdn.jsdelivr.net https://script.crazyegg.com https://static.cloudflareinsights.com https://www.google.com https://www.gstatic.com https://bam.nr-data.net https://hm.baidu.com/hm.js https://www.clarity.ms https://www.googleadservices.com blob: https://vjs.zencdn.net/5.0/video.min.js; object-src 'self' 'unsafe-inline' 'unsafe-eval' https: data; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://acsbapp.com https://sc-static.net https://tr.snapchat.com https://maps.googleapis.com https://fonts.googleapis.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com https://cdnapisec.kaltura.com https://cfvod.kaltura.com https://vjs.zencdn.net/5.0/video-js.min.css; frame-ancestors 'self'; report-uri /report-csp-violation
x-ah-environmentprod
x-cacheHIT
x-cache-hits157
x-content-type-optionsnosniff
x-dns-prefetch-controloff
x-frame-optionsSAMEORIGIN
x-request-idv-f894d8f2-74c2-11f0-b72a-1be4259af463
x-xss-protection1; mode=block
server-timingcfCacheStatus;desc="HIT"
servercloudflare
statuscode200
http_versionHTTP/2

Factores externos

Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 5.267 dominios de referencia.
Esta página recibe un total de 377.278 backlinks.
Esta página recibe backlinks de 3.748 direcciones IP distintas.

Backlinks desde Wikipedia

Descubre más links en la función de búsqueda de Wikipedia

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files

Disallow: /web.config
# Paths (clean URLs)

Disallow: /comment/reply/
Disallow: /filter/tips

Disallow: /search/




# Paths (no clean URLs)

Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips

Disallow: /index.php/search/




Disallow: /*printable
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /de-de/sites/novartis_de/files/*FAQ*
Disallow: /de-de/sites/novartis_de/files/*RMP*
Disallow: /*/spc/*FAQ*
Disallow: /*/spc/*RMP*
Disallow: /*FAQ*
Disallow: /*RMP*

User-agent: GPTBot
Crawl-delay: 2

User-agent: bingbot
Crawl-delay: 2

User-agent: GoogleOther
Crawl-delay: 2

Páginas similares

Snippet (vista previa de los resultados de búsqueda)

www.novartis.com
Novartis
Working together, we can reimagine medicine to improve and extend people’s lives.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Novartis66%Check
medicine66%Check
reimagine medicine58%Check
People52%Check
Working50%Check
Live50%Check
extend people49%Check
Novartis Foundation48%Check
Q2 202548%Check
lives46%Check
Mostrar más palabras clave

¡Analiza ya hasta 25.000 páginas de novartis.com!

Probar gratis
Garantizada la gratuidad durante la fase de prueba.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Aviso legal | Privacidad y Cookies

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses